NeoMed Management is an international investment firm, exclusively focussing on the healthcare and life science industry. NeoMed has established four funds, with total committed capital exceeding $200 million.

NeoMed invests in young companies with outstanding growth prospects. Portfolio companies typically develop innovative products addressing inadequately served medical needs in the following industry sectors: pharmaceuticals, biotechnology drugs, diagnostics, medical devices and instruments.

NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has backed companies in the USA and Europe, including Scandinavia, Switzerland, Germany and the UK.

Neomed has offices in Norway, Switzerland and the US East Coast.